Your browser doesn't support javascript.
loading
Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysis.
Corbaux, Pauline; You, Benoit; Glasspool, Rosalind M; Yanaihara, Nozomu; Tinker, Anna V; Lindemann, Kristina; Ray-Coquard, Isabelle L; Mirza, Mansoor R; Subtil, Fabien; Colomban, Olivier; Péron, Julien; Karamouza, Eleni; McNeish, Iain; Kelly, Caroline; Kagimura, Tatsuo; Welch, Stephen; Lewsley, Liz-Anne; Paoletti, Xavier; Cook, Adrian.
Afiliação
  • Corbaux P; EA UCBL/HCL 3738, Centre pour l'lnnovation en Cancérologie de Lyon (CICLY), Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, Lyon, France; Medical Oncology, Institut de Cancérologie et d'Hématologie Universitaire de Saint-Étienne (ICHUSE), Centre Hospitalier Universitaire de Saint-Eti
  • You B; EA UCBL/HCL 3738, Centre pour l'lnnovation en Cancérologie de Lyon (CICLY), Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, Lyon, France; Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, Centre Hospitalier Lyon-Sud, GINECO, GINEGEPS, Lyon, Fran
  • Glasspool RM; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, UK.
  • Yanaihara N; Department of Obstetrics and Gynecologye, The Jikei University School of Medicine, Tokyo, Japan.
  • Tinker AV; Medical Oncology, BC Cancer - Vancouver, Vancouver, Canada.
  • Lindemann K; Department of Gynaecological Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Ray-Coquard IL; Medical Oncology Department, Centre Léon Bérard, GINECO, Lyon, France.
  • Mirza MR; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Clinical Trial Unit, Nordic Society of Gynaecological Oncology, Copenhagen, Denmark.
  • Subtil F; Department of Biostatistics, Hospices Civils de Lyon, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, CNRS UMR 5558, Claude Bernard University Lyon 1, Lyon, France.
  • Colomban O; EA UCBL/HCL 3738, Centre pour l'lnnovation en Cancérologie de Lyon (CICLY), Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, Lyon, France.
  • Péron J; Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, Centre Hospitalier Lyon-Sud, GINECO, GINEGEPS, Lyon, France; Department of Biostatistics, Hospices Civils de Lyon, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, CNRS UMR 5558, Clau
  • Karamouza E; Institut Gustave Roussy, Office of Biostatistics and Epidemiology, Université Paris-Saclay, Villejuif, France; Inserm, Université Paris-Saclay, CESP U1018, Oncostat, labelled Ligue Contre le Cancer, Villejuif, France.
  • McNeish I; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Kelly C; Cancer Research UK Clinical Trial Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Kagimura T; Foundation for Biomedical Research and Innovation at Kobe, Translational Research Center for Medical Innovation, Kobe, Japan.
  • Welch S; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
  • Lewsley LA; Cancer Research UK Clinical Trial Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Paoletti X; Institut Curie, St Cloud, France.
  • Cook A; Medical Research Council Clinical Trials Unit, University College London, London, UK.
Eur J Cancer ; 191: 112966, 2023 09.
Article em En | MEDLINE | ID: mdl-37542936

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article